The wild EpiPen price hike points to a looming pharmaceutical crisis
“I LEGISLATED” IS NOT A PHRASE TYPICALLY ASSOCIATED with corporate executives, who lack constitutional powers. Yet during a television interview on Aug. 25, Mylan CEO Heather Bresch used just those words as she described a program that expanded the availability of her company’s EpiPen epinephrine injectors, which deliver epinephrine during allergic reactions, in schools across the country. Bresch made herself personally responsible for the law.
As the daughter of Joseph Manchin III, the
